Navigation Links
DuPont Science Leader Urges U.S. House Committee to Continue Federal Investment in Transformative, Clean Energy Technologies

DuPont Biotechnology Vice President Testifies Before U.S. House Science and Technology Committee

Washington (Vocus) January 27, 2010 -- DuPont Applied BioSciences Vice President of Technology John Pierce told members of the U.S. House of Representatives Science and Technology Committee that the U.S. Department of Energy (DOE) Advanced Research Projects Agency-Energy (ARPA-E) “serves a valuable role by focusing efforts on the critical energy sector as a powerful springboard for promising pre-market concepts.”

“DuPont and its partners have been conducting research programs to develop new clean energy technologies that are now nearing commercialization including the company’s two advanced biofuels programs,” Pierce said. “For example, the pre-commercial demonstration facility for the company’s cellulosic ethanol joint venture, DuPont Danisco Cellulosic Ethanol (DDCE), which is based on technology that has derived great benefit from DOE partnerships, has recently started production while the demonstration facility for the company’s biobutanol joint venture, Butamax™ Advanced Biofuels is expected to start up this year.”

DuPont and Bio Architecture Lab recently were awarded a $9 million matching grant from ARPA-E for a third generation biofuels research program to determine if sugars from macroalgae -- or seaweed -- can be efficiently converted to biobutanol. The project will complement the efforts under way in the Butamax™ joint venture to commercialize a multi-generational pipeline of isobutanol technologies from grain and cellulosic biomass that is the result of extensive research and technology investment by DuPont and BP.

“Support from the DOE and ARPA-E has allowed us to tackle this very challenging technology program of seaweed to butanol conversion,” Pierce said. “Our R&D portfolio is driven by market needs and expected returns for our shareholders. This serves near- and mid-term market needs well. Public-private partnerships best serve the pursuit of riskier, transformational technologies.”

DuPont is a science-based products and services company. Founded in 1802, DuPont puts science to work by creating sustainable solutions essential to a better, safer, healthier life for people everywhere. Operating in more than 70 countries, DuPont offers a wide range of innovative products and services for markets including agriculture and food; building and construction; communications; and transportation.

The DuPont Oval Logo, DuPont™, The miracles of science™ and Butamax™ are registered trademarks or trademarks of DuPont or its affiliates.


Read the full story at

Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

Related biology technology :

1. DuPont Leaders Brief Investors on Agriculture Businesses
2. DuPont, Genencor International and Tate & Lyle Honored for Groundbreaking Work in Developing Bio-PDO(TM)
3. DuPont and Plantic Technologies Announce Starch-Based Bio Materials Collaboration
4. DuPont Named Among Top Biotechnology Employers by Science Magazine
5. Biotechnology Needed to Help Meet Growing Global Needs for Food, Feed, Fuel and Materials, DuPont Chairman & CEO Says at World Food Prize
6. DuPont Joint Venture with Chinese Biotech Firm Strengthens Gene Discovery Research Efforts
7. DuPont Congratulates Growers Planting Pioneer(R) Brand Sorghum Hybrids in Winning Majority of National Categories in Yield Contest
8. DuPont Names Nicholas Fanandakis as Group Vice President - DuPont Applied BioSciences
9. DuPont Chief Science & Technology Officer Offers Perspectives on Science and Global Policymaking at Davos World Economic Forum
10. DuPont and Precision BioSciences Collaborate to Accelerate Crop Product Development
11. Research Confirms Better Oil from New DuPont High Oleic Soybean Trait
Post Your Comments:
Related Image:
DuPont Science Leader Urges U.S. House Committee to Continue Federal Investment in Transformative, Clean Energy Technologies 
(Date:11/24/2015)... , Nov. 24, 2015 According to two new ... 2005. This is something that many doctors, scientists, and public ... questions remains: with fewer PSA tests being done, will there ... Dr. David Samadi, "Despite the efforts made ... remains the second leading cancer cause of death in men, ...
(Date:11/23/2015)... HONG KONG, Nov. 23, 2015 China Cord ... "Company"), China,s leading provider of cord blood collection, laboratory ... services, today announced its preliminary unaudited financial results for ... 2016 ended September 30, 2015. --> ... Highlights , Revenues for the second quarter of ...
(Date:11/23/2015)... 23, 2015 The royalty-free a ... to develop daclatasvir for 112 low- and ... --> --> The Medicines Patent ... C medicine, signing an agreement with Bristol-Myers Squibb for daclatasvir, ... multiple genotypes of the HCV virus.  The royalty-free licence will ...
(Date:11/23/2015)... Nov. 23, 2015  CryoLife, Inc. (NYSE: CRY ), ... cardiac and vascular surgery, announced today that it will participate ... Conference on Wednesday, December 2, 2015 at The New York ... Pat Mackin , President and Chief Executive Officer. ... Executive Officer. --> A live webcast of ...
Breaking Biology Technology:
(Date:11/9/2015)... ) ... "Global Law Enforcement Biometrics Market 2015-2019" ... ) has announced the addition of ... 2015-2019" report to their offering. ... ) has announced the addition of the ...
(Date:11/4/2015)... 2015 --> ... by Transparency Market Research "Home Security Solutions Market - Global ... - 2022", the global home security solutions market is expected to ... The market is estimated to expand at a CAGR ... 2022. Rising security needs among customers at homes, the ...
(Date:10/29/2015)... Minn. , Oct. 29, 2015   MedNet ... supports the entire spectrum of clinical research, is pleased ... Minnesota High Tech Association (MHTA) as one of only ... in the "Software – Small and Growing" category. The Tekne ... individuals who have shown superior technology innovation and leadership. ...
Breaking Biology News(10 mins):